Works by Spin, Eva L.

Empagliflozin and Dapagliflozin Reduce ROS Generation and Restore NO Bioavailability in Tumor Necrosis Factor α-Stimulated Human Coronary Arterial Endothelial Cells.

Published in:

Cellular Physiology & Biochemistry (Cell Physiol Biochem Press GmbH & Co. KG), 2019, v. 53, n. 5, p. 865, doi. 10.33594/000000178

By:

• Uthman, Laween;
• Homayr, Anna;
• Juni, Rio P.;
• Spin, Eva L.;
• Kerindongo, Raphaela;
• Boomsma, Marleen;
• Hollmann, Markus W.;
• Preckel, Benedikt;
• Koolwijk, Pieter;
• van Hinsbergh, Victor W. M.;
• Zuurbier, Coert J.;
• Albrecht, Martin;
• Weber, Nina C.

Publication type:

Article